# The Medicines (Products for Human Use — Fees) Regulations 1995, Paragraph 3: Marketing authorizations


Where, for the purposes of Commission Regulation (EC) No. 541/95, the United Kingdom is the reference member State as defined in Article 2.2 of that Regulation, the fee payable under regulation 7(1) in connection with an application for variation of a marketing authorization shall be—
(a) where the application is a Type I Application, £230;
(b) where the application is a Type II Application, £410;
(c) where the application is for a Type II complex variation, £10,520.

---
Source: https://www.legislation.gov.uk/uksi/1995/1116/schedule/1/part/III/paragraph/3 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-1995/schedule-1/part-III/paragraph-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.